Beatrice Detti

About

Beatrice Detti is a leading figure in the surgical and radiotherapeutic management of prostate cancer, with a career dedicated to refining treatment strategies for improved patient outcomes. Her research focuses on two critical frontiers: salvage therapies for recurrent disease and the comparative effectiveness of robotic versus open surgical techniques. Detti’s most influential work, cited 50 times, demonstrates the viability of robotic stereotactic retreatment for biochemical control in previously irradiated patients with recurrent prostate cancer, offering a less invasive salvage option. She has also made pivotal contributions to understanding functional recovery after radical prostatectomy. Her 2013 study, with 24 citations, rigorously compared bilateral nerve-sparing robotic-assisted radical prostatectomy (RARP) to retropubic open prostatectomy, revealing that while RARP significantly accelerates continence recovery, it does not confer an advantage in erectile function recovery. This nuanced finding underscores her commitment to evidence-based patient selection, challenging assumptions about robotic surgery’s universal superiority. Detti’s work bridges surgical innovation and long-term quality of life, providing clinicians with actionable data to tailor treatments. Her research remains essential reading for urologists and oncologists navigating the complexities of prostate cancer care.

Research Focus

Key Achievements

Top Papers

1. 1
   Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer

   50 citations · 2017
2. 2
   Bilateral nerve sparing robotic-assisted radical prostatectomy is associated with faster continence recovery but not with erectile function recovery compared with retropubic open prostatectomy: The need for accurate selection of patients

   24 citations · 2013

Key Collaborators

Contact & Links